Decade of SBRT use seals its role in early lung cancer

Long-term experience using high-dose stereotactic body radiotherapy (SBRT) confirms that this highly focused, rigidly delivered, and tightly controlled radiation approach results in excellent local control and minimal toxicity in most patients with medically inoperable, early-stage lung cancer, report researchers from the Cleveland Clinic Foundation.